Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 9, 2012

 

 

LOGO

ARCHER-DANIELS-MIDLAND COMPANY

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   1-44   41-0129150

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

4666 Faries Parkway

Decatur, Illinois

  62526
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (217) 424-5200

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.05. Costs Associated with Exit or Disposal Activities.

On January 11, 2012, Archer-Daniels-Midland Company (the “Company”) committed to a planned reduction of its salaried workforce. Please see Exhibit 99.1 to this Current Report on Form 8-K, which is incorporated into this Item 2.05 by reference for additional information regarding this event. All of the pre-tax charge described in the release is expected to result in future cash expenditures.

Item 2.06. Material Impairments.

On January 9, 2012, the Company determined that a charge for impairment would be taken by the Company due to a change in circumstances and certain actions taken by the Company impacting its commercial alliance with Metabolix, Inc. and Telles, LLC, the Company’s joint venture with Metabolix. Please see Exhibit 99.2 to this Current Report on Form 8-K, which is incorporated into this Item 2.06 by reference for additional information regarding this event.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

The following exhibits are filed or furnished herewith:

 

99.1    Press release dated January 11, 2012
99.2    Press release dated January 12, 2012


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ARCHER-DANIELS-MIDLAND COMPANY
Date: January 13, 2012     By   /s/ David J. Smith
      David J. Smith
      Executive Vice President, Secretary and General Counsel


EXHIBIT INDEX

 

Number

  

Description

   Method of filing  
99.1    Press release dated January 11, 2012      Filed electronically   
99.2    Press release dated January 12, 2012      Filed electronically